EFFIE RAHMAN, MD
Ophthalmology Physician · BELLAIRE, TX
Individual Active NPI 1154777969
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 722 | 13,487 | $8,558,065 | $2,587,978 | $2,043,447 |
| 2023 | 752 | 9,656 | $7,996,260 | $2,527,521 | $1,999,073 |
| 2022 | 332 | 1,720 | $1,056,819 | $406,388 | $322,333 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 4,801 | $35 | $27 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 1,485 | $147 | $117 |
| J0178 | Injection, aflibercept, 1 mg | 1,438 | $822 | $654 |
| 92134 | Imaging of retina | 1,408 | $39 | $29 |
| J0177 | Injection, aflibercept hd, 1 mg | 1,024 | $330 | $263 |
| 67028 | Injection of drug into eye | 934 | $127 | $97 |
| 92014 | Established patient complete exam of visual system | 777 | $120 | $87 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 668 | $225 | $179 |
| J2778 | Injection, ranibizumab, 0.1 mg | 220 | $153 | $122 |
| 92250 | Photography of the retina | 154 | $35 | $27 |
| 92004 | New patient complete exam of visual system | 75 | $143 | $104 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 56 | $121 | $86 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | T4830 | TX |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | T4830 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1154438927
- NPI 1124237300
- NPI 1366445645
- NPI 1598296246
- NPI 1952922494
- NPI 1245761972
- NPI 1205011780
- NPI 1619610136
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.